TherapeuticsMD
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $784 | $952 | $393 | $667 |
Gross Profit | 688 | 952 | 393 | 667 |
EBITDA | 149 | -223 | -688 | -974 |
EBIT | 53 | -319 | -783 | -1,074 |
Net Income | 152 | 551 | -653 | 252 |
Net Change In Cash | 784 | 952 | 393 | 667 |
Free Cash Flow | 1,046 | 324 | 686 | 17 |
Cash | 7,115 | 6,069 | 5,745 | 5,059 |
Basic Shares | 11,574 | 11,574 | 11,552 | 11,532 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,761 | $1,302 | $69,963 | $2,573 |
Gross Profit | 1,761 | 1,302 | 68,566 | 1,171 |
EBITDA | -2,983 | -8,084 | 11,863 | -70,841 |
EBIT | -3,492 | -8,523 | 10,663 | -71,577 |
Net Income | -2,181 | -10,278 | 111,997 | -172,415 |
Net Change In Cash | 1,761 | 1,302 | 69,963 | 2,573 |
Cost of Revenue | -15,364 | |||
Free Cash Flow | 732 | -48,141 | -4,433 | -147,845 |
Cash | 5,059 | 4,327 | 38,067 | 64,907 |
Basic Shares | 11,532 | 10,441 | 9,028 | 7,960 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.05 |
2025-03-31 | $0.02 |
2024-12-31 | $0.02 |
